Turk Ilac ve Serumnayi (IST:TRILC) Other Current Liabilities: ₺179 Mil (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IST:TRILC Turk Ilac ve Serum Sanayi IST:TRILC
61 GF Score
Price ₺1.51
GF Value ₺3.63
Valuation Possible Value Trap
! 11 Warning Signs
View Full Analysis

What is Turk Ilac ve Serumnayi Other Current Liabilities?

Turk Ilac ve Serumnayi IST:TRILC +9.42% 61 Other Current Liabilities is ₺179 Mil as of Sep. 2025. GuruFocus rates IST:TRILC with a GF Score™ of 61/100 and a GF Value™ of ₺3.63 (Possible Value Trap). The stock has 11 warning signs investors should review.

Turk Ilac ve Serumnayi's other current liabilities for the quarter that ended in Sep. 2025 was ₺179 Mil.

Turk Ilac ve Serumnayi's quarterly other current liabilities declined from Mar. 2025 (₺418 Mil) to Jun. 2025 (₺145 Mil) but then increased from Jun. 2025 (₺145 Mil) to Sep. 2025 (₺179 Mil).

Turk Ilac ve Serumnayi's annual other current liabilities increased from Dec. 2022 (₺4 Mil) to Dec. 2023 (₺23 Mil) and increased from Dec. 2023 (₺23 Mil) to Dec. 2024 (₺69 Mil).

Turk Ilac ve Serumnayi Other Current Liabilities Related Terms

Turk Ilac ve Serumnayi Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Turk Ilac ve Serumnayi's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Turk Ilac ve Serumnayi Other Current Liabilities Chart

Turk Ilac ve Serumnayi Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Liabilities
12.60 2.80 3.60 22.60 69.10

Turk Ilac ve Serumnayi Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.05 69.10 418.28 144.97 179.50
IST:TRILC
61GF Score
Turk Ilac ve Serum Sanayi IST:TRILC
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Turk Ilac ve Serumnayi Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of ₺179 Mil mean?
Turk Ilac ve Serumnayi (IST:TRILC) has a Other Current Liabilities of ₺179 Mil as of Sep. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Turk Ilac ve Serumnayi.
Is Turk Ilac ve Serumnayi's Other Current Liabilities too high?
Turk Ilac ve Serumnayi's current Other Current Liabilities is ₺179 Mil. Overall, Turk Ilac ve Serumnayi has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Turk Ilac ve Serumnayi's Other Current Liabilities compare to ZTS and UTHR?
Turk Ilac ve Serumnayi's Other Current Liabilities of ₺179 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Turk Ilac ve Serumnayi. Turk Ilac ve Serumnayi's current Other Current Liabilities is ₺179 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Turk Ilac ve Serumnayi stock overvalued right now?
Based on GuruFocus' analysis, Turk Ilac ve Serumnayi (IST:TRILC) is currently considered Possible Value Trap. The stock's GF Value™ is ₺3.63, compared to a current price of ₺1.51 — trading 58.4% below its estimated fair value. The current Other Current Liabilities is ₺179 Mil. Turk Ilac ve Serumnayi's overall GF Score™ is 61/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Turk Ilac ve Serumnayi (IST:TRILC), the current Other Current Liabilities is ₺179 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Turk Ilac ve Serumnayi (IST:TRILC) Overvalued in 2026?

Based on GuruFocus' analysis, Turk Ilac ve Serumnayi stock appears to be undervalued. The current stock price of ₺1.51 is trading 58.4% below its estimated GF Value™ of ₺3.63. GuruFocus considers Turk Ilac ve Serumnayi to be Possible Value Trap.

Key valuation signals for IST:TRILC:

  • Other Current Liabilities: ₺179 Mil
  • GF Value™: ₺3.63 vs. price of ₺1.51 (58.4% below fair value)
  • GF Score™: 61/100 with 11 warning signs

No single metric tells the full story. See the IST:TRILC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Turk Ilac ve Serumnayi Business Description

Address Bugduz Mahalle Enver Pasa Cadde, No: 8 Akyurt, Ankara, TUR, TR 06750
Turk Ilac ve Serum Sanayi is engaged in the production of human pharmaceuticals and vaccines.
61GF Score

Get the complete analysis for IST:TRILC

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺1.51
Price
₺3.63
GF Value